Unknown

Dataset Information

0

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.

ABSTRACT:

SUBMITTER: Hall VG 

PROVIDER: S-EPMC8385563 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Improved immunogenicity following the third dose of BNT162b2 mRNA vaccine in heart transplant recipients.
| S-EPMC9383557 | biostudies-literature
Unknown Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.
| S-EPMC10037915 | biostudies-literature
Unknown A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients.
| S-EPMC9015954 | biostudies-literature
Unknown Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.
| S-EPMC8842265 | biostudies-literature
Unknown Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patients.
| S-EPMC10354405 | biostudies-literature
Unknown A third dose of COVID-19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant.
| S-EPMC9880636 | biostudies-literature
Unknown mRNA-1273 COVID-19 vaccine induces CD4+ T-cell responses among solid organ transplant recipients.
| S-EPMC12004975 | biostudies-literature
Unknown Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
| S-EPMC8628360 | biostudies-literature
Unknown Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
| S-EPMC9006415 | biostudies-literature
Unknown Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients.
| S-EPMC10818923 | biostudies-literature